William W. LiMD
Dr. Li is president, medical director, and co-founder of the Angiogenesis Foundation. He trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical development for 22 years. Under Dr. Li’s leadership, the Foundation has developed a unique social enterprise model based on national and international collaborations with leading medical academic centers around the world, biopharmaceutical innovators, the National Institutes of Health, National Cancer Institute, and medical associations. The Foundation’s work has led to the realization of 27 new treatments for diseases ranging from cancer to blindness to diabetic complications. Having testified and presented before congressional and other government panels on the impact of angiogenesis in healthcare, Dr. Li lectures widely on angiogenesis-related topics in front of clinical, government, and industrial audiences. He is involved in global efforts to advance the application of angiogenesis to health and wellness, and is a member of the Clinton Global Initiative, has designed programs featured at the World Economic Forum, and launched the Eat to Beat Cancer, and Do iT Yourself Health campaigns to bring science- and evidence-based health recommendations to the public.
Dr. Li has been published in Science, The New England Journal of Medicine, The Lancet, and other leading peer-reviewed medical journals. Receiving his AB with honors from Harvard College and his MD from the University of Pittsburgh School of Medicine, Dr. Li completed his internship, residency, and fellowship training in General Internal Medicine at the Massachusetts General Hospital in Boston. He has held appointments on the clinical faculties of Harvard Medical School, Tufts University School of Veterinary Medicine, and is currently a Visiting Assistant Professor of Medicine at Dartmouth Medical School. Dr. Li is an Honorary Fellow of the American College of Wound Care Specialists and has served as advisor and consultant to leading global public and private companies.